Cowen and Company’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Cowen and Company’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$5K	–	894
2022 Q3	$5K	Buy	+100,000	New	+$1.32M	﹤0.01%	531

Cowen and Company's FMTX Position: Q4 2022 in Review

Cowen and Company sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 100,000 shares — an estimated $5K sold.

Cowen and Company first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Cowen and Company reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Cowen and Company sold 100,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $5K.
Cowen and Company first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Cowen and Company's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $5K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.